Obtaining Advance Waivers In PE Transactions

Law360, New York (March 18, 2010, 11:21 AM ET) -- Consider the following hypothetical situation:

You work for a private equity firm (PE Firm), and sit on several boards of directors of portfolio companies as a representative of your firm, including one that is in the health care field (Company HC). You are approached during a cocktail party by an acquaintance who knows that you work for a private equity firm that makes investments in health care-related companies.

Your acquaintance’s business (Company T) is in the health care industry, and as it so happens, your acquaintance...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles